Tissue-engineered decellularized extracellular matrix (ECM) scaffolds hold great potential to
address the donor shortage as well as immunologic rejection attributed to cells in …

One of the main goals of tissue engineering and regenerative medicine is to develop skin
substitutes for treating deep dermal and full thickness wounds. In this regard, both scaffold …

Stem cell therapies offer a great promise for regenerative and reconstructive medicine, due
to their self-renewal and differentiation capacity. Although embryonic stem cells are …

Ischemia-reperfusion injury (I/RI), produced by an initial interruption of organ blood flow and
its subsequent restoration, contributes significantly to the pathophysiologies of stroke …

The placenta is the main organ that allows the fertilized oocyte to develop and mature. It
allows the fetus to grow in the prenatal period by transferring oxygen and nutrients between …

Bone marrow-derived cells (BMDCs) are heterogeneous populations in which not only
pluripotent stem cells, namely, hematopoietic stem cells (HSCs), mesenchymal stem cells …

Background: Mesenchymal stem cells (MSCs) and scaffold combination constitute a
promising approach currently adopted for tissue engineering. Umbilical cord-derived …

The placenta, with the amniotic fluid, umbilical cord, and the cord blood can be often
classified as pregnancy specific biological substances with enormous applications in …

Ischemic stroke remains the leading cause of neurologically based morbidity and mortality.
Current stroke treatment is limited to two classes of FDA-approved drugs: thrombolytics …